Pandemic offers AZ a blockbuster return Anyone who still thinks that AstraZeneca paid too much when it offered a hefty premium for MedImmune's shares should check out a new report from Jefferies International, which estimates that the global swine flu windfall will be worth … [Read more...] about AstraZeneca Cashes In On Global Swine Flu Windfall